chr11-95836162-G-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_016156.6(MTMR2):​c.1756C>A​(p.Arg586Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0276 in 1,612,476 control chromosomes in the GnomAD database, including 1,070 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.037 ( 158 hom., cov: 32)
Exomes 𝑓: 0.027 ( 912 hom. )

Consequence

MTMR2
NM_016156.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.04

Publications

5 publications found
Variant links:
Genes affected
MTMR2 (HGNC:7450): (myotubularin related protein 2) This gene is a member of the myotubularin family of phosphoinositide lipid phosphatases. The encoded protein possesses phosphatase activity towards phosphatidylinositol-3-phosphate and phosphatidylinositol-3,5-bisphosphate. Mutations in this gene are a cause of Charcot-Marie-Tooth disease type 4B, an autosomal recessive demyelinating neuropathy. Alternatively spliced transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
MTMR2 Gene-Disease associations (from GenCC):
  • demyelinating hereditary motor and sensory neuropathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Charcot-Marie-Tooth disease type 4B1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 11-95836162-G-T is Benign according to our data. Variant chr11-95836162-G-T is described in ClinVar as Benign. ClinVar VariationId is 306536.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.04 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0797 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTMR2NM_016156.6 linkc.1756C>A p.Arg586Arg synonymous_variant Exon 14 of 15 ENST00000346299.10 NP_057240.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTMR2ENST00000346299.10 linkc.1756C>A p.Arg586Arg synonymous_variant Exon 14 of 15 1 NM_016156.6 ENSP00000345752.6

Frequencies

GnomAD3 genomes
AF:
0.0369
AC:
5593
AN:
151772
Hom.:
159
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0567
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0173
Gnomad ASJ
AF:
0.0176
Gnomad EAS
AF:
0.000966
Gnomad SAS
AF:
0.0869
Gnomad FIN
AF:
0.0770
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0235
Gnomad OTH
AF:
0.0368
GnomAD2 exomes
AF:
0.0347
AC:
8709
AN:
251076
AF XY:
0.0378
show subpopulations
Gnomad AFR exome
AF:
0.0540
Gnomad AMR exome
AF:
0.0101
Gnomad ASJ exome
AF:
0.0166
Gnomad EAS exome
AF:
0.000761
Gnomad FIN exome
AF:
0.0798
Gnomad NFE exome
AF:
0.0230
Gnomad OTH exome
AF:
0.0338
GnomAD4 exome
AF:
0.0267
AC:
38934
AN:
1460586
Hom.:
912
Cov.:
32
AF XY:
0.0289
AC XY:
21019
AN XY:
726608
show subpopulations
African (AFR)
AF:
0.0573
AC:
1915
AN:
33422
American (AMR)
AF:
0.0111
AC:
496
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.0170
AC:
444
AN:
26084
East Asian (EAS)
AF:
0.000529
AC:
21
AN:
39682
South Asian (SAS)
AF:
0.0907
AC:
7823
AN:
86236
European-Finnish (FIN)
AF:
0.0767
AC:
4097
AN:
53388
Middle Eastern (MID)
AF:
0.0675
AC:
389
AN:
5760
European-Non Finnish (NFE)
AF:
0.0199
AC:
22066
AN:
1110984
Other (OTH)
AF:
0.0279
AC:
1683
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
2034
4068
6102
8136
10170
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
848
1696
2544
3392
4240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0368
AC:
5589
AN:
151890
Hom.:
158
Cov.:
32
AF XY:
0.0397
AC XY:
2947
AN XY:
74248
show subpopulations
African (AFR)
AF:
0.0565
AC:
2343
AN:
41452
American (AMR)
AF:
0.0173
AC:
263
AN:
15240
Ashkenazi Jewish (ASJ)
AF:
0.0176
AC:
61
AN:
3464
East Asian (EAS)
AF:
0.000968
AC:
5
AN:
5164
South Asian (SAS)
AF:
0.0866
AC:
416
AN:
4806
European-Finnish (FIN)
AF:
0.0770
AC:
814
AN:
10574
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0235
AC:
1597
AN:
67872
Other (OTH)
AF:
0.0360
AC:
76
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
265
530
794
1059
1324
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0247
Hom.:
46
Bravo
AF:
0.0311
Asia WGS
AF:
0.0330
AC:
115
AN:
3478
EpiCase
AF:
0.0252
EpiControl
AF:
0.0247

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Charcot-Marie-Tooth disease type 4B1 Benign:2
Jun 02, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Charcot-Marie-Tooth disease Benign:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease type 4 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
5.3
DANN
Benign
0.81
PhyloP100
1.0
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61735577; hg19: chr11-95569326; COSMIC: COSV108145943; COSMIC: COSV108145943; API